Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSV | O60911 | 1/20 | 0.39 |
| ▸ | CTSL | P07711 | 1/20 | 0.39 |
| ▸ | CTSB | P07858 | 1/20 | 0.39 |
| ▸ | ELANE | P08246 | 1/20 | 0.39 |
| ▸ | CMA1 | P23946 | 1/20 | 0.39 |
| ▸ | CTSS | P25774 | 1/20 | 0.39 |
| ▸ | CTSK | P43235 | 1/20 | 0.39 |
| ▸ | CTSF | Q9UBX1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10141057 | 1.00 | CTSV (0.39) | CTSVCTSLCTSBELANECMA1 | |
| SCHEMBL10140264 | 0.93 | CTSV (0.47) | CTSVCTSLCTSBELANECMA1 | |
| SCHEMBL13689612 | 0.93 | CTSV (0.47) | CTSVCTSLCTSBELANECMA1 | |
| SCHEMBL14451234 | 0.93 | CTSV (0.47) | CTSVCTSLCTSBELANECMA1 | |
| SCHEMBL10141053 | 0.91 | CTSS (0.47) | CTSVCTSLCTSBELANECMA1 | |
| SCHEMBL12605761 | 0.91 | CTSS (0.47) | CTSVCTSLCTSBELANECMA1 | |
| SCHEMBL14451514 | 0.88 | CTSV (0.36) | CTSVCTSLCTSBELANECMA1 | |
| SCHEMBL13690090 | 0.88 | CTSV (0.36) | CTSVCTSLCTSBELANECMA1 | |
| SCHEMBL12605760 | 0.86 | CTSV (0.46) | CTSVCTSLCTSBELANECMA1 | |
| SCHEMBL10141050 | 0.86 | CTSV (0.46) | CTSVCTSLCTSBELANECMA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7592316-B2 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | SCHERING CORPORATION (US) | 2009-09-22 | — | — | US | disclosed |
| US-7592316-B2 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | SCHERING CORPORATION (US) | 2009-09-22 | — | — | US | disclosed |
| US-7244721-B2 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | SCHERING CORPORATION (US) | 2007-07-17 | — | — | US | disclosed |
| US-7244721-B2 | Peptides as NS3-serine protease inhibitors of hepatitis C virus | SCHERING CORPORATION (US) | 2007-07-17 | — | — | US | disclosed |